Information was received from a manufacturer's representative (rep) regarding an implantable neurostimulator (ins) for the treatment of spinal pain.It was reported that the patient has a rash all over their body.No allergies were confirmed.The rep stated that the patient was sent to a dermatologist.The patient doesn't have seasonal allergies and is not on antibiotics that could have contributed to the rash.The patient saw a dermatologist.The rep stated that the dermatologist thinks that it looks like a metal reactions.The patient was given a steroid and may be sent for allergy testing.No device allegations were reported.Additional information was received from the rep stating that the physician referred the patient to a dermatologist and the patient was prescribed meds for the rash.The rep provided a sheet that includes all metals to physicians for their review.No allergy test was performed at this time.The rep spoke to the patient and his rash had improved but still has some residual lesions.Dermatologist was not sure of the cause however suspected nickel or gold could have caused such a rash.If rash continues they plan to refer the patient to (b)(6) for an allergy test.Additional information was received from the patient via manufacturer representative.It was reported that the a blood test was performed indicating that the patient had high levels of chromium and nickel in their blood, which might have been responsible for the rash and discomfort.The patient stated that the medicine they were provided with had reduced the severity of the rash, but that the rash would continue each time they recharged their implant battery using the system.The patient mentioned that they wanted to reach a solution that would help their stimulator be both effective and problem-free.No further complications were reported or anticipated.Additional information was received from the consumer reporting the metal-llt analysis report indicated: bone cement particles mildly reactive, chromium reactive, nickel reactive, vanadium mildly reactive, zirconium mildly reactive.The consumer further reported via a rep that the patient gets reaction a when charging, that was somewhat systemic in that it was in the patient's back, arms and sometime their face.The patient relies on system for pain control using high dose settings but hasn't gotten the best pain relief, thought the system was providing more than 50% relief.The patient has complained of taking a long time t o charge (everyday - sometimes for 2-3 hours) and their wife does most of the charging since the patient has limited range of motion.Low dose programming was tried on the patient but the patient couldn't stand the tingling sensation, therefore, needs high dose programming.The patient was charging daily as they were using hd settings.The rep will be attending an appointment the patient has in two days with their doctor.No further complications were reported.
|